11号染色体长臂存在缺失的骨髓增生异常综合征与SF3B1突变的高频率相关。 - Suppr

MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations.

作者信息

Stengel A, Kern W, Meggendorfer M, Haferlach T, Haferlach C

机构信息

MLL Munich Leukemia Laboratory, Munich, Germany.

出版信息

Leukemia. 2017 Sep;31(9):1995-1997. doi: 10.1038/leu.2017.180. Epub 2017 Jun 8.

DOI:10.1038/leu.2017.180

PMID:28592886

Abstract

摘要

相似文献

MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations.

Leukemia. 2017 Sep;31(9):1995-1997. doi: 10.1038/leu.2017.180. Epub 2017 Jun 8.

Alteration of SF3B1 and SRSF2 Genes in Myelodysplastic Syndromes Patients in Upper Northern Thailand.

Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1215-1221. doi: 10.31557/APJCP.2019.20.4.1215.

The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome.

Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1825-1831. doi: 10.22034/APJCP.2018.19.7.1825.

Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.

Crit Rev Oncol Hematol. 2019 Jan;133:74-83. doi: 10.1016/j.critrevonc.2018.07.013. Epub 2018 Aug 3.

Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.

Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):528-532. doi: 10.1016/j.clml.2018.05.016. Epub 2018 May 26.

Clonal shifts in MDS - from SF3B1 to EZH2.

Leuk Lymphoma. 2018 Dec;59(12):2994-2997. doi: 10.1080/10428194.2018.1443452. Epub 2018 Apr 4.

SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications.

Leukemia. 2020 Sep;34(9):2525-2530. doi: 10.1038/s41375-020-0753-9. Epub 2020 Feb 19.

Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes.

Int J Lab Hematol. 2021 Jun;43(3):426-432. doi: 10.1111/ijlh.13400. Epub 2020 Nov 21.

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q).

Blood Cancer J. 2017 Dec 18;7(12):658. doi: 10.1038/s41408-017-0017-8.

Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype.

Br J Haematol. 2021 May;193(4):798-803. doi: 10.1111/bjh.17414. Epub 2021 Mar 25.

引用本文的文献

Classical meets malignant hematology: a case of acquired εγδβ-thalassemia in clonal hematopoiesis.

Haematologica. 2024 Aug 1;109(8):2745-2748. doi: 10.3324/haematol.2024.285083.

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Blood Adv. 2022 Jan 25;6(2):386-398. doi: 10.1182/bloodadvances.2021005311.

Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes.

Int J Hematol. 2018 Dec;108(6):598-606. doi: 10.1007/s12185-018-2551-y. Epub 2018 Oct 23.

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q).

Blood Cancer J. 2017 Dec 18;7(12):658. doi: 10.1038/s41408-017-0017-8.

本文引用的文献

The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.

Leukemia. 2017 Mar;31(3):705-711. doi: 10.1038/leu.2016.263. Epub 2016 Sep 29.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Leukemia. 2014 Feb;28(2):241-7. doi: 10.1038/leu.2013.336. Epub 2013 Nov 13.

Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12.

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.

J Clin Oncol. 2012 Sep 20;30(27):3376-82. doi: 10.1200/JCO.2011.40.7379. Epub 2012 Aug 6.

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.

Blood. 2012 Apr 12;119(15):3578-84. doi: 10.1182/blood-2011-12-399337. Epub 2012 Mar 2.

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

J Clin Oncol. 2012 Mar 10;30(8):820-9. doi: 10.1200/JCO.2011.35.6394. Epub 2012 Feb 13.

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26.

Unraveling the molecular pathophysiology of myelodysplastic syndromes.

J Clin Oncol. 2011 Feb 10;29(5):504-15. doi: 10.1200/JCO.2010.31.1175. Epub 2011 Jan 10.

Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features.

Leuk Res. 2011 Mar;35(3):351-7. doi: 10.1016/j.leukres.2010.07.018. Epub 2010 Aug 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献